U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266818) titled 'A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)' on Dec. 01.
Brief Summary: The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Study Start Date: Dec. 17
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: MK-1167
Oral capsule administered once daily
DRUG: Placebo
Oral capsule administered once daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Sharp & Dohme LLC
Published by HT Digital Content Services with permission from Health Daily Digest....